[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
September 22/29, 2004

Rheumatoid Arthritis Trial

JAMA. 2004;292(12):1419. doi:10.1001/jama.292.12.1419-c

Researchers are launching a new study to determine how individuals with rheumatoid arthritis evaluate improvements in disease symptoms during treatment. Trial organizers said such a trial is needed because physicians generally evaluate the health of patients with rheumatoid arthritis by physically measurable criteria, but little attention is given to whether treatment results are meaningful to patients. Using patient-based criteria might help physicians determine if a new treatment is likely to be considered helpful by the patient.

First Page Preview View Large
First page PDF preview
First page PDF preview